{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T15:10:13Z","timestamp":1650726613443},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2775","type":"journal-article","created":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T23:35:51Z","timestamp":1417390551000},"page":"2711-2715","source":"Crossref","is-referenced-by-count":3,"title":["Anaplastic Lymphoma Kinase Gene Analysis as a Useful Tool for Identifying Primary Unknown Metastatic Lung Adenocarcinoma"],"prefix":"10.2169","volume":"53","author":[{"given":"Naoki","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Takahama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tadokoro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Kanaji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Dobashi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Bandoh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Muir C. Cancer of unknown primary site. Cancer 75: 353-356, 1995.","DOI":"10.1002\/1097-0142(19950101)75:1+<353::AID-CNCR2820751317>3.0.CO;2-P"},{"key":"2","unstructured":"2. Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12: 1272-1280, 1994."},{"key":"3","unstructured":"3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology [Internet]. [cited 2013 Dec 1]. Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/occult.pdf"},{"key":"4","unstructured":"4. Zhang MQ, El-Mofty SK, Davila RM. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer 114: 118-123, 2008."},{"key":"5","unstructured":"5. Califano J, Westra WH, Koch W, et al. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst 91: 599-604, 1999."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kanaji N, Bandoh S, Ishii T, et al. Detection of epidermal growth factor receptor mutation in a few cancer cells from transbronchial cytologic specimens by reverse transcriptase-polymerase chain reaction. Mol Diagn Ther 15: 353-359, 2011.","DOI":"10.1007\/BF03256471"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39: 1990-2005, 2003.","DOI":"10.1016\/S0959-8049(03)00547-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet 379: 1428-1435, 2012.","DOI":"10.1016\/S0140-6736(11)61178-1"},{"key":"9","unstructured":"9. Jaffer S, Bleiweiss IJ. Beyond hematoxylin and eosin: the role of immunohistochemistry in surgical pathology. Cancer Invest 22: 445-465, 2004."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Park SY, Kim BH, Kim JH, Lee S, Kang GH. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med 131: 1561-1567, 2007.","DOI":"10.5858\/2007-131-1561-POIMHD"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Stoll LM, Johnson MW, Gabrielson E, Askin F, Clark DP, Li QK. The utility of Napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. Cancer Cytopathol 118: 441-449, 2010.","DOI":"10.1002\/cncy.20108"},{"key":"12","unstructured":"12. National Cancer Institute. National Cancer Institute, Factsheet [Internet]. [cited 2013 Dec 1]. Available from: http:\/\/www.cancer.gov\/cancertopics\/factsheet\/Therapy\/targeted"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Antonescu CR. The role of genetic testing in soft tissue sarcoma. Histopathology 48: 13-21, 2006.","DOI":"10.1111\/j.1365-2559.2005.02285.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139, 2004.","DOI":"10.1056\/NEJMoa040938"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kwak EL, Bang Y-J, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363: 1693-1703, 2010.","DOI":"10.1056\/NEJMoa1006448"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chihara D, Suzuki R. More on crizotinib. N Engl J Med 364: 776-777; author reply 778, 2011.","DOI":"10.1056\/NEJMc1013325"},{"key":"17","unstructured":"17. Roskoski R. Jr. Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition. Pharmacological Res 68: 68-94, 2013."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/23\/53_53.2775\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T14:49:09Z","timestamp":1650725349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/23\/53_53.2775\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":17,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2775","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}